Seeing Is Believing
Currently out of the existing stock ratings of Andrew Cooper, 162 are a BUY (91.01%), 16 are a HOLD (8.99%).
Analyst Andrew Cooper, currently employed at RAYMOND JAMES, carries an average stock price target met ratio of 56.45% that have a potential upside of 21.62% achieved within 230 days.
Andrew Cooper’s has documented 335 price targets and ratings displayed on 24 stocks. The coverage is on Healthcare, Basic Materials, Industrials sectors.
Most recent stock forecast was given on HAE, Haemonetics at 03-Sep-2026.
Analyst best performing recommendations are on NTRA (NATERA).
The best stock recommendation documented was for GH (GUARDANT HEALTH) at 7/31/2025. The price target of $61 was fulfilled within 21 days with a profit of $20.02 (48.85%) receiving and performance score of 23.26.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 20-Jul-2021
$74
$6.85 (10.20%)
$60
9 days ago
(24-Sep-2026)
10/12 (83.33%)
$12.63 (20.58%)
214
Hold Since 26-Feb-2021
$46
$-21.15 (-31.50%)
$25
2 months 2 days ago
(31-Jul-2026)
11/11 (100%)
$2.29 (5.24%)
232
Hold Since 15-Dec-2025
$21
$-7.82 (-27.13%)
$18
7 months 7 days ago
(25-Feb-2026)
4/4 (100%)
$2.54 (13.76%)
32
Buy Since 08-Oct-2024
$22
$-6.82 (-23.66%)
$22
1 years 9 days ago
(23-Sep-2025)
5/11 (45.45%)
$6.43 (41.30%)
130
Buy Since 17-Apr-2024
$40
$11.18 (38.79%)
$40
1 years 4 months 27 days ago
(05-May-2025)
0/3 (0%)
$24.83 (163.68%)
Which stock is Andrew Cooper most bullish on?
What Year was the first public recommendation made by Andrew Cooper?